Myocarditis following rAd26 and rAd5 vector‐based COVID‐19 vaccine: case report

SARS‐CoV‐2 vaccines provide a safe solution with a major impact on reducing the spread of the virus and mild side effects. Research has shown rare cases of myocarditis after mRNA vaccines. This study presents a 29‐year‐old male with chest pain after 48 h of receiving rAd26 and rAd5 vector‐based COVI...

Descripción completa

Detalles Bibliográficos
Autores principales: Naghashzadeh, Farah, Shafaghi, Shadi, Dorudinia, Atosa, Naji, Seyed Alireza, Marjani, Majid, Amin, Ahmad, Mohamadifar, Arezoo, Noorali, Sima, Kashani, Babak Sharif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934948/
https://www.ncbi.nlm.nih.gov/pubmed/35106967
http://dx.doi.org/10.1002/ehf2.13821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934948/
https://www.ncbi.nlm.nih.gov/pubmed/35106967
http://dx.doi.org/10.1002/ehf2.13821

Ejemplares similares